Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2003, p. 3653-3656, Vol. 47, No. 11
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.11.3653-3656.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
G484S Amino Acid Substitution in Lanosterol 14-
Demethylase (ERG11) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate
Laura Rodero,1* Emilia Mellado,2 A. Carolina Rodriguez,1 Angela Salve,1 Liliana Guelfand,3 Pedro Cahn,3 Manuel Cuenca-Estrella,2 Graciela Davel,1 and Juan L. Rodriguez-Tudela2
Departamento Micología, Instituto Nacional de Enfermedades Infecciosas, ANLIS "Dr. Carlos G. Malbrán,",1
Hospital J. A. Fernandez, Buenos Aires, Argentina,3
Unidad de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain2
Received 2 May 2003/
Returned for modification 10 June 2003/
Accepted 11 August 2003
Five sequential Cryptococcus neoformans isolates recovered from an AIDS patient with recurrent meningitis were analyzed. Four isolates were fluconazole susceptible, while the fifth isolate developed fluconazole resistance. Analysis of the 14-
lanosterol demethylase gene (ERG11) showed a point mutation in the resistant strain responsible for the amino acid substitution G484S.
* Corresponding author. Mailing address: Departamento Micología, Instituto Nacional de Enfermedades Infecciosas, ANLIS "Dr. Carlos G. Malbrán," Av. Velez Sarsfield 563, (1281) Buenos Aires, Argentina. Phone and fax: 54-11-4302-5066. E-mail:
lrodero{at}anlis.gov.ar.
Antimicrobial Agents and Chemotherapy, November 2003, p. 3653-3656, Vol. 47, No. 11
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.11.3653-3656.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sheng, C., Miao, Z., Ji, H., Yao, J., Wang, W., Che, X., Dong, G., Lu, J., Guo, W., Zhang, W.
(2009). Three-Dimensional Model of Lanosterol 14{alpha}-Demethylase from Cryptococcus neoformans: Active-Site Characterization and Insights into Azole Binding. Antimicrob. Agents Chemother.
53: 3487-3495
[Abstract]
[Full Text]
-
Sionov, E., Chang, Y. C., Garraffo, H. M., Kwon-Chung, K. J.
(2009). Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with Virulence. Antimicrob. Agents Chemother.
53: 2804-2815
[Abstract]
[Full Text]
-
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., Monk, B. C.
(2009). Efflux-Mediated Antifungal Drug Resistance. Clin. Microbiol. Rev.
22: 291-321
[Abstract]
[Full Text]
-
Cowen, L. E., Steinbach, W. J.
(2008). Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance. Eukaryot Cell
7: 747-764
[Full Text]
-
Sanguinetti, M., Posteraro, B., La Sorda, M., Torelli, R., Fiori, B., Santangelo, R., Delogu, G., Fadda, G.
(2006). Role of AFR1, an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans. Infect. Immun.
74: 1352-1359
[Abstract]
[Full Text]
-
Perkins, A., Gomez-Lopez, A., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M.
(2005). Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother
56: 1144-1147
[Abstract]
[Full Text]